Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium cromoglycate and montelukast for mannitol-induced bronchoconstriction in asthma
ACTRN12608000393358Phase 4Completed
- Sponsor
- Dr. Sandra D. Anderson
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sodium cromoglycate and montelukast in asthma (3 arms), sponsored by Dr. Sandra D. Anderson. Primary endpoints: Maximum percent fall in FEV1 from prechallenge value after mannitol challenge and Area above the FEV1 time recovery curve comparing placebo, sodium cromoglycate, and sodium cromoglycate plus montelukast. Started Jan 2005; status: completed.
02
Drugs
sodium cromoglycatemontelukast
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12608000393358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000393358.